As the Managed Health Care sector experiences a strong performance, this analysis will spotlight on how specific tickers contributed to this uptrend over the last month. We’ll concentrate on $CI, $HUM, $MOH, $ELV, and $OSCR, diving into their performance and market behavior.
💼 Managed Health Care Sector: Elevate Your Trading Game with AI Robots! 💼
If you're keen on exploring the Managed Health Care group, we have the perfect tools to assist you in your trading journey. 🏥📈
🔄 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" is designed to help you navigate markets in decline. Whether you're a seasoned trader or just starting, this AI robot can provide valuable insights and strategies to thrive in challenging conditions.
⬆️ On the flip side, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is your go-to companion when markets are on the rise. It offers a tailored approach to capitalize on upward trends and maximize your trading potential.
With these AI-powered tools at your disposal, you can confidently trade within the Managed Health Care sector, adapting to different market conditions and making informed decisions. Elevate your trading game and embark on a journey of trading excellence! 📊🚀
Tickers in this Group:
$CI - $HUM - $UNH - $MOH - $CNC - $CVS - $ELV - $OSCR - $ALHC
Description
Managed Health Care firms offer crucial health, medical, and disability plans aiming to streamline the cost of health care services. Major firms in this sector, including Aetna, Humana Inc., Cigna, UnitedHealthcare, provide insurance through various channels, ultimately aiming to make health care more accessible and affordable to the public.
Market Cap Analysis
With a group average market capitalization of $96.3B, the sector presents a diverse range of companies from $UNH at the pinnacle with $473B to $OSCR at $1.2B. This vast difference outlines the sector's diversity, offering traders various options to invest based on their market cap preference.
High and Low Price Notable News
The sector observed an average weekly growth of 0.45%, with a monthly enhancement of 5.77%. $ALHC leads the growth at 8%, while $ELV experienced a 1.53% decline. These fluctuations provide traders with insights into the tickers’ volatility and potential investment return.
Volume Insights
The sector’s stocks recorded an average weekly volume growth of -1.11%, with a significant decrease in the monthly and quarterly volume growth, which traders should consider when planning their investment strategies.
Fundamental Analysis Ratings
Ticker Spotlight: $CI, $HUM, $MOH, $ELV, $OSCR
$CI - Cigna Group (The)
$CI has shown a promising upward trend with its 10-day moving average crossing above its 50-day counterpart, signaling a potential buying opportunity with an 86% chance of continued growth.
$HUM - Humana
With its price surging above the 50-day moving average, $HUM indicates a strong upward trend, providing traders an 80% likelihood of further price increase in the upcoming month.
$MOH - Molina Healthcare
$MOH broke its lower Bollinger Band, suggesting a potential rise back towards the middle band. With an 81% chance of upward movement, this ticker presents a promising buy for traders.
$ELV - Elevance Health
$ELV is expected to rebound from its lower Bollinger Band, offering traders a probable 78% chance of engaging in a continued uptrend in the next month.
$OSCR - Oscar Health
Breaking its lower Bollinger Band, $OSCR provides traders with a compelling buy option, boasting an 83% probability of sustaining its upward trend.
With the Managed Health Care sector experiencing a +strong performance, tickers like $CI, $HUM, $MOH, $ELV, and $OSCR are at the forefront of this positive movement. As traders, understanding the nuances of each ticker’s performance, market cap, and volume growth is crucial for making informed investment decisions in this thriving sector.
CI saw its Momentum Indicator move below the 0 level on November 17, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 55 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 59%.
The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 29 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.
CI moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for CI moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 226 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
CI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 175 of 274 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.820) is normal, around the industry mean (3.520). P/E Ratio (12.077) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (0.739) is also within normal values, averaging (0.786). CI has a moderately high Dividend Yield (0.021) as compared to the industry average of (0.009). P/S Ratio (0.264) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. CI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of health insurance services
Industry ManagedHealthCare